На мой взгляд достаточно неожиданные первые новости с PCR2011:
[
Ссылки доступны только зарегистрированным пользователям ]
Цитата:
|
In-hospital hematoma greater than 5 cm, the study's primary endpoint, was less common with FemoSeal use (2.2% vs. 6.7% with manual compression; P = 0.002). At 14 days, access-site related major adverse vascular events (MAVE) and other outcomes were equivalent between groups
|